Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-05-17 @ 5:34 PM
Study NCT ID:
NCT02029092
Status:
COMPLETED
Last Update Posted:
2017-09-28
First Post:
2013-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BIOFLOW III Satellite-ELADIS Orsiro Stent System
Sponsor:
C.E.M. Biotronik, S.A.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Coronary Artery Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | International | View |
| None | Multicenter | View |
| None | Observational registry | View |
| None | Orsiro Drug Eluting Stent (DES) | View |
| None | Stenting | View |
| None | Treatment of coronary artery disease | View |
| None | Coronary revascularization | View |
| None | Percutaneous Coronary Intervention (PCI) | View |
| None | STEMI | View |
| None | NSTEMI | View |
| None | Ischemia | View |
| None | Angina | View |
| None | Acute Myocardial Infarction (AMI) | View |
| None | Small Vessels | View |
| None | Chronical Total Occlusion (CTO) | View |